Philips MRI Scanner to be Used in Prestigious 6 Year Project

Royal Philips ElectronicsScientists from Guys' and St Thomas', King's College, London, Imperial College, London and University of Oxford will use a Philips state-of-the-art MRI scanner combined with specially developed imaging techniques to investigate the wombs of pregnant women and image their babies' brains, even while the fetuses are moving.

To deliver this ambitious project new MRI facilities have been installed at St Thomas' Hospital, creating a dedicated imaging suite, integrated with the neonatal critical care unit and a wide bore scanner for fetal imaging. Philips Healthcare has supplied an Achieva TX MRI system and an Avalon fetal monitor, and will be providing ongoing support to ensure the systems consistently provide peak performance.

The researchers will use the advanced imaging techniques to map how the human brain grows and forms connections, with the aim of mapping out for the first time how the brain assembles itself, and also observe how brain connections and patterns of activity, seen on older subjects, emerge as babies grow in the womb and just after birth. Up to 1,500 subjects will be studied to examine both normal development and also explore early signs of disabilities such as autism and attention deficit disorders. The objective is to create a "connectome", a kind of wiring diagram of the fetal and infant brain showing the formation of brain structures such as the cerebral cortex, where 'thinking' occurs, or the hippocampus, which is central to memory, and the connections between them.

Professor David Edwards, director of the Centre for the Developing Brain at King's said "We want to create a series of atlases showing the human brain at different stages in development. Eventually, we hope to have enough data to compare the brains of children who go on to develop normally with those who develop conditions like autism and attention deficit disorders, so that we can see if such conditions have their origins in the way the brain developed in the womb."

MRI is already used to image brains of unborn babies, often after ultrasound exams have shown potential abnormalities, and it is also increasingly used to help in the management of premature babies and other vulnerable infants. The information provided is becoming more and more important as new treatments are developed that can improve the outcome for babies at risk of long-term brain damage occurring around the time of birth. However, while established imaging techniques provide detailed anatomical information and reveal if there is structural brain damage, mapping of brain connectivity and emerging brain function is a task at the limits of current capabilities. The team will, therefore, have to develop both advanced imaging methods and new ways to analyze the images to extract the vital connectome information.

Jo Hajnal, professor of imaging science at King's, a physicist who specializes in imaging subjects who cannot remain still while they are scanned said "We will scan about 1,500 children; about 500 will be fetuses, another 500 will be new-born normal babies, and the rest will be at-risk babies, including 200 premature babies and about 300 babies identified as being at higher risk of development autism."

Professor Hajnal goes on "The fetal scans let us look back into the womb and see how the brain assembles itself, while the normal babies will give us a sense of just what a brain looks like, and how it works when a person enters the world. We can compare these images with what we see in the brains of at-risk babies and maybe find out what makes them different."

Once the images have been collected, advanced computational analysis methods will be developed and applied to extract connectome information. This critical part of the project will be led by Professor Daniel Rueckert, Department of Computing, Imperial College London, and Professor Steve Smith of Oxford University's centre for Functional MRI of the Brain.

About Royal Philips Electronics
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 116,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

Researchers Invent AI Model to Design Ne…

Researchers at McMaster University and Stanford University have invented a new generative artificial intelligence (AI) model which can design billions of new antibiotic molecules that are inexpensive and easy to...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Greater Manchester Reaches New Milestone…

Radiologists and radiographers at Northern Care Alliance NHS Foundation Trust have become the first in Greater Manchester to use the Sectra picture archiving and communication system (PACS) to report on...

Powerful New AI can Predict People'…

A powerful new tool in artificial intelligence is able to predict whether someone is willing to be vaccinated against COVID-19. The predictive system uses a small set of data from demographics...

AI-Based App can Help Physicians Find Sk…

A mobile app that uses artificial intelligence, AI, to analyse images of suspected skin lesions can diagnose melanoma with very high precision. This is shown in a study led from...

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...